ArticleTherapeutic advances in hematology2025

Venetoclax added to CLAG regimen might improve the outcome of patients with relapsed/refractory acute myeloid leukemia.

Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.